Overexpression of CDKN2A and CDKN2B in murine models is associated with pancreatic islet hypoplasia and diabetes [67], [68], and there is also emerging evidence that vascular cell senescence involving these pathways is involved in the pathogenesis of atherosclerosis [69], [70]. Here, CDKN2B is linked to atherosclerosis.